Alnylam chief commercialization officer Tolga Tanguler to depart in December 2026
ALNY•Alnylam Pharmaceuticals said Executive Vice President and Chief Commercialization Officer Tolga Tanguler will depart in December 2026.
ALNY•ALNY•ALNY•Alnylam Pharmaceuticals said Executive Vice President and Chief Commercialization Officer Tolga Tanguler will depart in December 2026.
Alnylam Pharmaceuticals announced on November 4, 2026, that Executive Vice President and Chief Commercialization Officer Tolga Tanguler will depart in December 2026.
